Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: The spider genus Schiødte, 1849 contains 69 species, endemic to Indochina and Southeast Asia. Only one species is currently known from the Chinese province of Yunnan: Yu, Zhang & Zhang, 2021.
New Information: A new species, Lin & Li, sp. nov., is described from Yunnan, China, on the basis of both sexes. Photos and a morphological description of the new species are provided.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10838109 | PMC |
| http://dx.doi.org/10.3897/BDJ.11.e113290 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Commercially processed complementary foods (CPCFs) are consumed in Kenya, but little is known about caregiver perceptions and reasons for their consumption. We explored caregiver perceptions, motivations and reasons for purchasing CPCFs. This cross-sectional mixed-methods study was conducted in Nairobi among caregivers of children aged 6-23 months.
View Article and Find Full Text PDFPotential predictors of COVID-19 booster vaccine confidence among adult people: a cross-sectional analysis amid the Omicron surge in Southern Bangladesh.
Vaccine
September 2025
Department of Pharmacy, University of Rajshahi, Rajshahi 6205, Bangladesh.
Despite the therapeutic potential of the primary vaccine series, a lack of confidence in the COVID-19 booster vaccine poses a threat to public health and undermines its coverage at the national, regional, and global levels. This study aimed to understand COVID-19 booster vaccine confidence (CBVC) among Bangladeshi adults aged 18-49 and the potential predictors of CBVC. In line with STROBE guidelines, a face-to-face cross-sectional survey was conducted from June 15 to August 31, 2023 during the spread of the SARS-CoV-2 Omicron variant.
View Article and Find Full Text PDFInfluenza vaccination coverage assessments by race and ethnicity can identify populations less protected from influenza morbidity and mortality and help focus vaccination efforts. Across eight Vaccine Safety Datalink health systems, we identified influenza vaccines administered from August 1 through March 31 each season from 2017 to 18 through 2022-23 using electronic health records linked to immunization registries. We calculated crude vaccination coverage for each season among people in five age groups (6 months-8 years, 9-17, 18-49, 50-64, and ≥ 65 years) by self-reported race and ethnicity.
View Article and Find Full Text PDFSafety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial.
EBioMedicine
September 2025
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Background: Invasive non-typhoid Salmonella (iNTS) is a leading cause of morbidity and mortality in sub-Saharan Africa. We assess the safety and immunogenicity of an outer membrane vesicle vaccine (iNTS-GMMA) derived from the two most common serovars, S. Enteritidis (SEn) and S.
View Article and Find Full Text PDFHow perioperative processes and patient-reported outcomes contribute to persistent postoperative opioid use: A cohort study linking clinical and health claims data.
Eur J Anaesthesiol
September 2025
From the Department of Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich Schiller University Jena (MK, CA, JTD, NR, PB, WM, DS), Department of Anaesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Centre and Saarland University Faculty of Medici
Background: Opioid analgesics play a major role in perioperative pain management, yet their use can lead to persistent postoperative opioid use (PPOU), with significant societal and health costs. Patient-specific risk factors of PPOU are well described but little is known about factors that can be controlled by clinicians.
Objectives: To find PPOU risk factors among perioperative processes and pain-related patient-reported outcomes (PROs) on the first postoperative day.